The CGuardTM Embolic Prevention System (EPS) is a novel mesh carotid stent designed to improve patient safety through sustained embolic protection.1,2
Dual Layer Design
CGuardTM EPS is designed to prevent peri-procedural and late embolisation by trapping potential emboli against the arterial wall while maintaining perfusion to the external carotid artery.2,4
Data from the PARADIGM-Extend study in patients with symptomatic or increased-stroke-risk asymptomatic carotid stenosis demonstrate sustained embolic protection with CGuardTM EPS over a 48-month follow-up period:1
|Myocardial infarction or non-cerebral vascular accident||3||3||2||2|
The rapid exchage (Rx) system delivers the self-expanding CGuardTM EPS to the carotid artery where it adapts to the vessel diameter, eliminating the need for a tapered design.2,3
InspireMD has established CGuardTM Centers of Excellence at leading hospitals in Europe to help educate and share experiences with CGuardTM through workshops and live cases.
Watch case studies of CGuardTM EPS implantation performed at our Centers of Excellence.
*60mm sizes are not available in Australia
CGuardTM EPS is CE Mark approved. It is not approved for sale in the U.S.A.
References: 1. Musialek P et al. PARADIGM-Extend Prospective Academic Trial: Accumulating long-term evidence for MicroNet-covered stent safety and stroke prevention efficacy. Presentation at ESC Congress 2019, Paris, France, 31 August 2019 to 4 September 2019. 2. Wissgott C et al. J Endovasc Ther 2017;24(1):130–137. 3. Musialek P, Hopkins LN, Siddiqui AH. Postepy Kardiol Interwencyjnej 2017;13(2):95–106. 4. Schofer J et al. JACC Cardiovasc Interv 2015;17(8):1229–1234. 5. CGuard™ Instructions for Use.